Diabetes Australia Research Trust 2012 Grant Round
Viertel Fellowship Award
Dr Karly Sourris
Baker IDI Heart and Diabetes Institute
Type 1 & Type 2
Interactions between glucagon like peptide (GLP-1) and the receptor for advanced glycation end products (RAGE) in the development and progression of diabetic nephropathy.
Underworks Millennium Type 2 Award
Professor Julie Owens
University of Adelaide
Type 2
Identifying epigenetic pathways from maternal obesity to type 2 diabetes in offspring
Millennium Type 1 Award
Dr Cecile King
Garvan Institute
Type 1
Interleukin-21 as a therapeutic target in type 1 diabetes
General Grants
Professor Paul McMenanim
Monash University
Type 1 and Type 2
The role of resident corneal immune cells in the development of diabetes associated corneal neuropathy
Dr Antonia Miller
Monash University
Type 1 and Type 2
Evaluation the molecular detail of epigenetic memory in diabetic retinopathy
Associate Professor Matthew Watt
Monash University
Type 2
Does lipid accumulation in hypothalamic neurons contribute to the development of whole-body insulin resistance?
Dr Elizabeth Barr
Baker IDI Heart and Diabetes Institute
Type 2
Improving the prediction of diabetes and cardiovascular disease in urban Indigenous Australians: follow-up of the DRUID study cohort
Associate Professor Leonie Heilbronn
University of Adelaide
Type 2
Does Hyperbaric Oxygen Therapy Modulate Insulin Resistance?
Professor Jennifer Wilkinson-Berka
Monash University
Type 1 and Type 2
The contribution of NADPH oxidase and microglia to diabetic retinopathy
Associate Professor Mark Gorrell
Centenary Institute
Type 2 and Complications
Targeting proteases for a novel therapy for type 2 diabetes and liver complications
Dr Phillip Kantharidis
Baker IDI Heart and Diabetes Institute
Type1 and Type 2
The microRNA-29 is a regulator of diabetic renal fibrosis
Dr Paul Gregorevic
Baker IDI Heart and Diabetes Institute
Type1 and Gestational
Evaluating follistatin as a novel therapeutic for diabetes, and for diabetic complications
Associate Professor Sofianos Andrikopoulos
University of Melbourne
Type 1
Targeted treatment for fibrosis with FT61 will improve renal and heart function in experimental model of diabetic nephropathy and cardiomyopathy
Dr Martha Lappas
University of Melbourne
Gestational
Does the maternal environment contribute to fetal overgrowth in women with gestational diabetes?
Professor Joseph Proietto
University of Melbourne
Type 1
Obesity in older adults with diabetes: effect of exercise and weight loss on physiology and function.
Dr David Stapelton
University of Melbourne
Type 2
Molecular basis for impaired hepatic glycogen metabolism in Type 2 diabetes
Professor Jennifer Couper
University of Adelaide
Type 1
Does Metformin improve vascular health in overweight youth with type 1 diabetes?
Associate Professor Rebecca Ritchie
Baker IDI Heart and Diabetes Institute
Type 1
The novel HNO donor 1-nitroscocyclohexyl acetate (1-NCA) blocks diabetes – induced cardiac dysfunction
Dr Yeesim Khew-Goodall
University of Adelaide
Type 2
A novel regulator of insulin-stimulated glucose uptake
Professor Margaret Morris
University of NSW
Type 2
How does early life stress (ELS) increase risk of metabolic disease and diabetes? Role of subsequent high fat diet (HFD) consumption, and stress later in life
Dr Sheila Patel
University of Melbourne
Type 2
The genetic influences on cardiac hypertrophy in type 2 diabetes
Dr John Wentworth
Walter and Eliza Hall Institute
Type 2 and Obesity
Lipid-induced inflammation and human insulin resistance
Dr Matthew Linden
RMIT University
Type 2
Using Evidence to Guide Treatment of Aspirin Resistance in Diabetes
Dr Myra Poon
The Children’s Hospital at Westmead
Type 1
The role of environmental factors in the development of microvascular and macrovascular complications in type 1 diabetes – A 14 year follow-up of an incident cohort
Dr Yinghua Yu
University of Wollongong
Type 2
How do distinct fatty acids affect central leptin sensitivity and glucose intolerance in obesity and Type II diabetes?
Professor Michael Davies
University of Sydney
Type 1 and Type 2
Role of high glucose in cellular dysfunction and cardiovascular disease in people with diabetes
Associate Professor Duncan Campbell
St Vincent’s Institute
Type 2
Mechanisms of diabetic cardiomyopathy
Dr Itamar Levinger
Victoria University
Type 2
Does undercarboxylated osteocalcin involved in increase insulin-stimulated skeletal muscle glucose uptake following muscle contraction?
Dr Georgia Frangioudakis
Garvan Institute
Type 2
Adjustment of sphingolipid metabolism to enhance insulin action
Dr Lisa Moran
University of Adelaide
Type 2
Lifestyle interventions during pregnancy to reduce type 2 diabetes mellitus in overweight and obese women
Associate Professor John Whitehead
Mater Medical Research Institute
Type 2
Characterising a novel adipogenic pathway to identify new therapeutic targets for obesity related diabetes
Professor Mark Febbraio
Baker IDI Heart and Diabetes Institute
Type 2
Effect of adipose tissue specific deletion of Interleukin 6 on insulin sensitivity
Dr Morton Burt
Flinders University
Other
Effect of therapeutic glucocorticoids on insulin sensitivity, cardiovascular risk and energy metabolism in patients with inflammatory arthritis
Dr Nigel Turner
Garvan Institute
Type 2
Regulation of mitochondrial function and insulin action in skeletal muscle by lysine acetylation
Dr Kristine McGrath
University of Sydney
Type 2
Can HDL mimetics be used as a therapeutic option to restore insulin sensitivity?
Dr Xiaoyu Wang
University of Sydney
Type 2
Incretins as Therapy in Diabetic Cardiomyopathy
Dr Elke Sokoya
Flinders University
Other
Novel mechanisms underlying cerebral vascular dysfunction in metabolic syndrome
Professor Karin Jandeleit-Dahm
Baker IDI Heart and Diabetes Institute
Type 1
Targeting a new microRNA in diabetes associated atherosclerosis and restenosis
Professor Ann Simpson
University of Technology
Type 1
Gene and stem cell therapy for diabetes mellitus
Dr Carsten Schmitz-Peiffer
Garvan Institute
Type 2
The role of branched chain amino acid degradation in the improvement of glucose homeostasis caused by protein kinase C epsilon deletion
Dr Virginie Lecomte
University of NSW
Type 1 and Type 2
Effect of paternal obesity on insulin sensitivity and glucose tolerance of offspring
Professor George Muscat
University of Queensland
Type 2
The nuclear receptor, RorY, and the regulation of skeletal muscle insulin sensitivity
Dr Kathryn Backholer
Baker IDI Heart and Diabetes Institute
Type 2
Long-term population health impact of type 2 diabetes screening and prevention strategies among Australian adults
Behavioural General Grant Award
Dr Jennifer Wong
Monash University
Type 2
Improving the metabolic health of patients treated with Clozapine, an atypical antipsychotic.
Professor Brian Oldenburg
Monash University
Type 2
The process of care in managing people with type 2 diabetes: What is the impact of peer support on uptake and effective implementation of care plans in the self-management of diabetes?
Professor Stephen Colagiuri
University of Sydney
Type 2 and other
Long-term follow up of the Sydney Diabetes Prevention Program (SDPP) cohort